Research shows promising results for a weekly injectable Parkinson's treatment that maintains consistent medication levels, ...

Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Mexican affiliate, Grupo Biotoscana de Especialidad S.A. de C.V., has ...

Levodopa is the most common medicine for Parkinson’s symptoms, but it’s also linked with a side effect called dyskinesia, jerking movements you can’t control. That makes some people question ...

Levodopa, aka l-DOPA, is an amino acid that serves as a natural precursor to a variety of different neurotransmitters, including dopamine.

Treatment of Parkinson's disease is in large part based on the administration of levodopa. The use of this drug is limited by the development of psychiatric complications, including a disorder ...

Levodopa that is administered in an immediate-release form has a clearance half-life of 1 to 3 hours, which can be prolonged by the inhibition of peripheral catechol- O -methyltransferase (COMT ...

A new pill, tavapadon, has shown potential in easing Parkinson’s symptoms while limiting side effects. In patients taking at least 400 mg of levodopa daily, tavapadon helped reduce motor ...

A study from Emory University suggests that levodopa, a medication that increases dopamine levels in the brain, may help treat individuals with depression who experience motivational impairments ...

The overall balance of risks and benefits favors levodopa over levodopa-sparing therapies for patients with newly diagnosed Parkinson's disease (PD), according to a study that showed levodopa had ...

In addition, responder rates were similar at 60 minutes (88% vs. 92%). The levodopa peak response occurred at 60 minutes (–24.3 vs –24.4).

Because levodopa and dopamine can generate reactive oxygen species and induce the degeneration of cultured dopamine neurons, concern has been raised that levodopa could enhance oxidative stress ...